Website & contact details
- Website
Fellows Research Centre Ltd
- Incorporated
- 1 August 2018 (8 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Accounts type
- Small
- Region
- East of England
- Address
- The Maylands BuildingMaylands AvenueHemel Hempstead Industrial EstateHemel HempsteadHP2 7TG
Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 14 August 2027
- Last conf. stmt
- 31 July 2026
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 1 August 2018
British
Born May 1979 (47)
Director · Appointed 1 August 2018
British
Born January 1974 (52)
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 1 August 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 10759004
Group structure 6 companies
Ownership group derived from the Companies House PSC register
Gama Healthcare Corporation Limited Owns 75–100% of shares
Carell Limited Owns 75–100% of shares
Fellows Research Centre Ltd This company Owns 75–100% of shares
Gama Healthcare Ltd Owns 75–100% of shares
Gama Property Corporation Limited Owns 75–100% of shares
Financials
Balance sheet as at 31 March 2025 · small accounts
- Net Assets
- £1,410,673
- Cash
- £5,661
- Employees
- 2
- Debt Ratio
- 46%
- Current Ratio
- 2.2x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | |
|---|---|---|
| Fixed Assets | £22,919 | £57,935 |
| Current Assets | £2,579,682 | £2,173,977 |
| Cash | £5,661 | £119 |
| Creditors (< 1 year) | £1,187,676 | £945,000 |
| Net Current Assets | £1,392,006 | £1,228,977 |
| Net Assets | £1,410,673 | £1,274,231 |
| Shareholder Funds | £1,410,673 | £1,274,231 |
What Fellows Research Centre say about themselves
“Constant innovation is vital. Emerging MDROs and established pathogens present new and unique challenges for delivering care. From our cutting-edge facility, our team work to create novel infection prevention solutions to protect patients.”
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Melbourn
London
Edinburgh
West Mains Road
Penicuik
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →